Australian GovernmentStudy Australia
University of Adelaide

Master of Biopharmaceutical Engineering


Course Details

Biopharmaceuticals have a critical role to play in improving global health. Recently, the development of mRNA and DNA vaccines to combat the COVID-19 pandemic has brought the work of biopharmaceutical engineers further into the public spotlight. The more effectively and efficiently these powerful vaccines or medicines can be designed and produced, the more lives they will save. With the biopharmaceuticals market valued at approximately $325. 17 billion USD in 2020, professionals with specialist biopharmaceutical engineering training are in demand worldwide. Our Master of Biopharmaceutical Engineering will prepare you to take up the challenge.

Qualification: Master Degree (By Coursework)

Course structure: To qualify for the degree of the Master of Biopharmaceutical Engineering, students must satisfactorily complete a program of study with a combined total of 48 units. If undertaking the Research Pathway, students must complete: Core courses to the value of 24 units; Elective courses to the value of 6 units; a major Research Project to the value of 18 units.

CRICOS Code: 0101345

Start date: July, 2024

Address

North Terrace

North Terrace

ADELAIDE, South Australia, 5005

Attendance options

  • Full-time - 2 years

Total tuition costs

AUD $104,000